FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On September 21, 2007
Docket # Title
1995S-0158 Community Disclosure of Institutional Review Boards
1996N-0417 CGMP in Mfg. Packing or Holding Dietary Supplements
2005N-0353 Agency Information Collection Activities; Proposed Collection; Comment Request; Pharmaceutical Development Study
2006N-0454 Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
2007N-0262 Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine)
2007N-0277 Food Labeling: Use of Symbols to Communicate Nutrition Information, Consideration of Consumer Studies and Nutritional Criteria; Public Hearing
2007N-0337 Agency Information Collection Activities: Proposed Collection; Comment Request; Radioactive Drug Research Committees
2007N-0347 Information Technology Strategic Planning; Public Meeting
2007P-0354 Refrain from approving Any Application for a Generic Thalidomide Product
1995S-0158 Community Disclosure of Institutional Review Boards
RPT 24 ROC Vol #: 58
1996N-0417 CGMP in Mfg. Packing or Holding Dietary Supplements
C 283 Norman Kjome Vol #: 54
C 284 J & V Small Vol #: 54
LET 1 Norman Kjome Vol #: 54
2005N-0353 Agency Information Collection Activities; Proposed Collection; Comment Request; Pharmaceutical Development Study
NAL 1 FDA Vol #: 1
2006N-0454 Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
C 2558 R Henry Vol #: 27
C 2559 B Weber Vol #: 27
C 2560 M Pointer Vol #: 27
C 2561 G Barnes Jr Vol #: 27
C 2562 N Hart Vol #: 27
C 2563 M Sherin Vol #: 27
C 2564 N Laughman Vol #: 27
C 2565 S. Barbe Vol #: 27
C 2566 B Polk Vol #: 27
C 2567 K Mundloch Vol #: 27
C 2568 D Monnig Vol #: 27
C 2569 P Stambler Vol #: 27
C 2570 L Davis Vol #: 27
C 2571 J Bennett Sr Vol #: 27
C 2572 D Lysne Vol #: 27
C 2573 J Pace Vol #: 27
C 2574 A Kriese Vol #: 27
C 2575 E Schweitzer Vol #: 27
C 2576 M Moe Vol #: 27
C 2577 L J Palmer Vol #: 27
C 2578 R Lakings Vol #: 27
C 2579 M Monger Vol #: 27
C 2580 T Covey Vol #: 27
C 2581 T Dawson Vol #: 27
C 2582 W Ginther Vol #: 27
C 2583 E Brown Vol #: 27
C 2584 E Brown Vol #: 27
C 2585 J Ingoglia Vol #: 27
C 2586 N Bischoff Vol #: 27
C 2587 G Gillstrap Vol #: 27
C 2588 R Dye Vol #: 27
C 2589 S Meyer Vol #: 27
C 2590 S Weiner Vol #: 27
C 2591 D Brinkman Vol #: 27
C 2592 D Kumferman Vol #: 27
C 2593 E Gray Vol #: 27
C 2594 D Schroog Vol #: 27
C 2595 J Dickey Vol #: 27
C 2596 S Murphy Vol #: 27
C 2597 J Taaffe Vol #: 27
C 2598 R Dunning Vol #: 27
C 2599 J Lees Vol #: 27
C 2600 M Krall Vol #: 27
C 2601 H Blevins Vol #: 27
C 2602 H Harbin Vol #: 27
C 2603 E Shalvey Jr Vol #: 27
C 2604 V Angel Vol #: 27
C 2605 L Casullo Vol #: 27
C 2606 T Hoover Vol #: 27
C 2607 E Blachly Vol #: 27
C 2608 J Gray Norris Vol #: 27
C 2609 B Eppert Vol #: 27
C 2610 J Branham Vol #: 27
C 2611 E Fry Vol #: 27
C 2612 J Reid Vol #: 27
C 2613 M Burrell Vol #: 27
C 2614 J Gutierrez Vol #: 27
C 2615 J Blount Vol #: 27
C 2616 S Blair Vol #: 27
C 2617 G Smiley Vol #: 27
C 2618 W Tuck Vol #: 27
C 2619 W Isle Vol #: 27
C 2620 J Pierce Vol #: 27
C 2621 B Shafer Vol #: 27
C 2622 C Hatcher Vol #: 27
C 2623 P Edminister Vol #: 27
C 2624 V Michael Vol #: 27
2007N-0262 Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine)
REF 1 OMB Review held on September 20, 2007 Vol #: 1
2007N-0277 Food Labeling: Use of Symbols to Communicate Nutrition Information, Consideration of Consumer Studies and Nutritional Criteria; Public Hearing
C 1 National Restaurant Association Vol #: 1
2007N-0337 Agency Information Collection Activities: Proposed Collection; Comment Request; Radioactive Drug Research Committees
N 1 FDA Vol #: 1
2007N-0347 Information Technology Strategic Planning; Public Meeting
NM 1 FDA Vol #: 1
2007P-0354 Refrain from approving Any Application for a Generic Thalidomide Product
ACK 1 FDA/DDM to Sidley Austin LLP Vol #: 1
CP 1 Celgene Corporation Vol #: 1

Page created on September 24, 2007 ue

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management